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ABSTRACT 
G-Proteins are membrane-bound beterotrimeric polypeptides that 
couple receptor signals to second messenger systems such as CAMP. 
Recently, point mutations at 2 codons of the highly preserved a-chain 
of G,, the adenyl cyclase-stimulating G-protein, were found in GH- 
secreting pituitary tumors. These mutations resulted in constitutively 
activated G,a and high intracellular CAMP levels. In addition, point 
mutations at similar codons of a different G-protein, G,o12, were re- 
ported in adrenocortical neoplasms, suggesting a potential role of this 
isoform in the genesis of these tumors. We reevaluated the frequency 
of constitutively activating point mutations in the a-chain of the 
stimulatory (G,ol) and inhibitory (Gicu2) G-proteins in human adreno- 
cortical tumors. Seven adrenocortical carcinomas, 2 human adrenocor- 
tical tumor cell lines, and 11 adrenocortical adenomas were studied. 
Genomic DNA was purified from either frozen tumor tissue or paraffin- 
embedded sections. Using specific primers and the polymerase chain 
reaction, DNA fragments surrounding codons 201 and 227 (G,oc) and 
179 and 205 (G,a2) were amplified and visualized on a 2% agarose gel. 
In a second asymmetric polymerase chain reaction, using nested 
primers, single stranded DNA was generated using l-10 FL of the 
initial amplification mixture and directly sequenced using the dideoxy 
chain termination method of Sanger. We found no mutations at codons 
201, 227 and 179, 205 of G,a and G,a2, respectively, in the tumors 
studied. We conclude that previously identified oncogenic point muta- 
tions in the stimulatory and inhibitory a-chain of G-proteins do not 
appear to be present at high frequency in adrenal neoplasms. Thus, the 
mechanism(s) of tumorigenesis in these tumors is different from that 
in GH-secreting adenomas and may involve oncogenic mutations of 
other cell constituents. (J Clin Endocrinol Metab ‘7’7: 1419-1422,1993) 
T WO DECADES ago, adrenocortical neoplasms were con- sidered rare. However, with wider application of ultra- 
sound, computed tomography, and, more recently, magnetic 
resonance imaging, it became evident that the prevalence of 
clinically silent, incidentally detected adrenal neoplasms is 
much higher than previously assumed (1). However, the 
tumorigenesis of adrenocortical neoplasms is not well under- 
stood, and the molecular mechanisms that lead to adrenal 
tumor formation have not been extensively studied. 
G-Proteins involved in signal transduction are heterotri- 
mers consisting of cy-, P-, and y-subunits that bind guanine 
nucleotide and interact with specific receptors and effecters 
(2). G-Protein activation normally requires the interaction of 
the inactive GDP-bound heterotrimer with a ligand-occupied 
receptor, resulting in the exchange of GTP for GDP and 
dissociation of the a-unit (3). Recently, mutations in the (Y- 
unit of G,, the adenylyl cyclase-stimulating protein, have 
been described in GH-secreting pituitary adenomas (4). 
These mutations caused an amino acid exchange at the highly 
conserved codons Arg*” and Gln227, resulting in a constitu- 
Received January 20, 1993. Accepted May 25, 1993. 
Address all correspondence and requests for reprints to: George I’. 
Chrousos, M.D., National Institutes of Health, Building 10, Room 
lON262, 9000 Rockville Pike, Bethesda, Maryland 20892. 
* Recipient of a fellowship from the Deutsche Forschungs-gemein- 
schaft (Re 752 2-l). 
tive activation of G,a by inhibition of endogenous GTPase 
activity. These putative oncogenic mutations, which were 
called Gsp, were found in approximately 40% of GH-pro- 
ducing tumors and 4% of thyroid tumors (5, 6). Point mu- 
tations at similar codons of a different G-protein, codons 179 
and 205 of G,a2, were reported in adrenocortical neoplasms, 
suggesting a potential role of mutated Gi(u2 (Gip 2) in the 
tumorigenesis of adrenocortical masses (5). However, the 
initially described series was rather small (n = ll), demon- 
strating mutations in three (27%) tumors. We, therefore, 
reevaluated the frequency of Gsp and Gip 2 in a larger series 
of adrenocortical tumors. 
Subjects and Methods 
Isolation of DNA from tissue specimens 
Adrenocortical tumor tissue was obtained at adrenalectomy from 18 
patients. DNA was isolated from 7 adrenocortical carcinomas and 11 
adrenocortical adenomas (for clinical data, see Table 1). In 10 cases, 
tumor DNA was extracted from paraffin-embedded sections accumu- 
lated over a 30.yr period. In 8 cases, frozen (-80 C) tumor tissue and 
corresponding normal leukocytic DNA were studied. In addition, DNA 
from the 2 currently available human adrenocortical tumor cell lines 
were studied. SW13, a nonsecretory human adrenocortical tumor cell 
line maintained in Ham’s F-10 medium with 10% fetal bovine serum, 
was received from the American Type Culture Collection (Rock- 
ville, MD). NC1 H-295, a human steroid-producing adrenocortical tumor 
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ABSTRACT 
G-Proteins are membrane-bound heterotrimeric polypeptides that 
couple receptor signals to second messenger systems such as cAMP. 
Recently, point mutations at 2 codons of the highly preserved a-chain 
of G" the adenyl cyc1ase-stimulating G-protein, were found in GH-
secreting pituitary tumors. These mutations resulted in constitutively 
activated G,a and high intracellular cAMP levels. In addition, point 
mutations at similar codons of a different G-protein, Gia2, were re-
ported in adrenocortical neoplasms, suggesting a potential role of this 
isoform in the genesis of these tumors, We reevaluated the frequency 
of constitutively activating point mutations in the a-chain of the 
stimulatory (G,a) and inhibitory (G io:2) G-proteins in human adreno-
cortical tumors, Seven adrenocortical carcinomas, 2 human adrenocor-
tical tumor cell lines, and 11 adrenocortical adenomas were studied. 
WO DECADES ago, adrenocortical neoplasms were con-
sidered rare, However, with wider application of ultra-
sound, computed tomography, and, more recently, magnetic 
resonance imaging, it became evident that the prevalence of 
clinically silent, incidentally detected adrenal neoplasms is 
much high er than previously assumed (1), However, the 
tumorigenesis of adrenocortical neoplasms is not wen under-
stood, and the molecular mechanisms that lead to adrenal 
tumor formation have not been extensively studied. 
G-Proteins involved in signal transduction are heterotri-
mers consisting of a-, ß-, and ')'-subunits that bind guanine 
nucleotide and interact with specific receptors and effectors 
(2), G-Protein activation normally requires the interaction of 
the inactive GDP-bound heterotrimer with a ligand-occupied 
receptor, resulting in the exchange of GTP for GDP and 
dissociation of the a-unit (3), Recently, mutations in the a-
unit of GS! the adenylyl cyclase-stimulating pro tein, have 
been described in GH-secreting pituitary adenomas (4), 
These mutations caused an amino acid exchange at the highly 
conserved co dons Arg201 and Gln227, resulting in a constitu-
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Genomic DNA was purified from either frozen tumor tissue or paraffin-
embedded sections, Using specific primers and the polymerase chain 
reaction, DNA fragments surrounding codons 201 and 227 (G,a) and 
179 and 205 (G io:2) were amplified and visualized on a 2% agarose geL 
In a second asymmetrie polymerase chain reaetion, using nested 
primers, single stranded DNA was generated using 1-10 ILL of the 
initial amplifieation mixture and directly sequenced using the dideoxy 
chain termination method of Sanger, We found no mutations at codons 
201, 227 and 179, 205 of G,a and Gia2, respectively, in the tumors 
studied, We conclude that previously identified oncogenie point muta-
tions in the stimulatory and inhibitory a-chain of G-proteins do not 
appear to be present at high frequency in adrenal neoplasms, Thus, the 
mechanism(s) of tumorigenesis in these tumors is different from that 
in GH-secreting adenomas and may involve oncogenic mutations of 
other cell constituents. (J Clin Endocrinol Metab 77: 1419-1422, 1993) 
tive activation of Gsa by inhibition of endogenous GTPase 
activity, These putative oncogenic mutations, which were 
called Gsp, were found in approximately 40% of GH-pro-
ducing tumors and 4% of thyroid tumors (5, 6), Point mu-
tations at similar codons of a different G-protein, codons 179 
and 205 of G;a2, were reported in adrenocortical neoplasms, 
suggesting a potential role of mutated G;a2 (Gip 2) in the 
tumorigenesis of adrenocortical masses (5), However, the 
initially described series was rather small (n = 11), demon-
strating mutations in three (27%) tumors, We, therefore, 
reevaluated the frequency of Gsp and Gip 2 in a larger series 
of adrenocortical tumors, 
Subjects and Methods 
Isolation of DNA from tissue specimens 
Adrenocortical tumor tissue was obtained at adrenalectomy from 18 
patients, DNA was isolated from 7 adrenocortical cardnomas and 11 
adrenocortical adenomas (for clinic l data, see Table 1), In 10 cases, 
tumor DNA was extracted from paraffin-embedded seetions accumu-
la t d over a 30-yr pcriod. In 8 ca ses, froz n (-80 C) tumor tissue and 
c rresponding normal leukocytic DNA we e studied, In addition, DNA 
from the 2 currently vailabl  human adrenocortical tumor cell lin s 
w re studi , SW13, a nonsecretory human adrenocortical tumo  cell 
line maintained in Ham's F-10 medium with 10% fetal bovine serum, 
was received from the American Type Culture C llection (Rock-
ville, MD), NCl H-295, a human steroid-producing adrenocortical tumor 
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TABLE 1. Clinical data of the patients whose tumors were studied 
Patient SC3 Age Tumor size 
no. (Yd (cm) 
Histology Clinical presentation 
1 F 15 25 x 17 x 8 Liver met., adren. cam. Virilization 
2 F 50 9x8x7 Adren. cart. Conn’s syndrome 
3 M 25 9x8x5 Adren. cart. Cushing’s syndrome, MEN I 
4 F 14 7~4x2 Liver met., adren. cart. Non-secretory tumor 
5 F 29 8X6X1 Brain met, adren. cart. Non-secretory tumor 
6 F 22 12 x 6 x 10 Adren. cart. Cushing’s syndrome 
7 F 27 17 cm diam. Adren. cart. Virilization 
8 F 67 2.5 cm diam. Adrenal adenoma Cushing’s syndrome 
9 F 65 4X5X3 Adrenal adenoma Cushing’s syndrome 
10 F 41 3 cm diam. Adrenal adenoma Conn’s syndrome 
11 F 49 3 cm diam. Adrenal adenoma Cushing’s syndrome 
12 F 50 1 cm diam. Adrenal adenoma Conn’s syndrome 
13 F 39 4X4X3 Adrenal adenoma Cushing’s syndrome 
14 F 51 1.5 cm diam. Adrenal adenoma Conn’s syndrome 
15 F 39 2X2X1 Adrenal adenoma Conn’s syndrome 
16 F 48 3x3x2 Adrenal adenoma Conn’s syndrome 
17 F 30 4x2x2 Adrenal adenoma Conn’s syndrome 
18 F 48 1x3 Adrenal adenoma Conn’s syndrome 
Adr. cant., Adrenocortical carcinoma; met., metastsis; diam., diameter; MEN I, multiple endocrine neoplasia type 1. 
DNA source 
Frozen tissue 
Frozen tissue 
Paraffin 
Paraffin 
Paraffin 
Paraffin 
Paraffin 
Frozen tissue 
Frozen tissue 
Frozen tissue 
Frozen tissue 
Frozen tissue 
Frozen tissue 
Paraffin 
Paraffin 
Paraffin 
Paraffin 
Paraffin 
cell line maintained in HITES (containing hydrocortisone, insulin, eth- 
anolamine and selenite) medium with 2% fetal bovine, was kindly 
provided by Dr. E. Gazdar (7). 
DNA preparation 
DNA was isolated from paraffin-embedded specimens (8), leukocytes, 
or frozen tumor sections obtained at surgery (9), as previously described. 
Tissue samples were derived from a central portion of the tumor to 
minimize the possibility of contamination with normal tissue. Repre- 
sentative sections of the tumor material were examined by light micros- 
copy and shown to consist of more than 90% tumor cells. For paraffin- 
embedded specimens, IO-pm sections were carefully cut and placed in 
sterile Eppendorf tubes using new gloves, forceps, and a cleaned micro- 
tome blade for every tumor block. 
Polymerase chain reaction (PCR) amplification of genomic 
DNA 
PCR was used to amplify DNA fragments surrounding codons 201 
and 227 of G$a and codons 179 and 205 of G,a2, respectively (10). One 
and 10 FL DNA preparation from paraffin-embedded tissues or 1 pg 
DNA from frozen tissue or leukocytic DNA were amplified in a IOO-rL 
PCR mixture containing deoxynucleotide triphosphates (200 wmol/L 
each), up- and down-stream oligonucleotide primers (0.3 pmol/L each), 
0.01% gelatin, 50 mmol/L KCI, 10 mmol/L Tris-HCl (pH 8.3), 1.5 mmol/ 
L MgC12, and 2.5 U Ta9 polymerase (Perkin-Elmer Cetus, Norwalk, CT). 
The following primers were used: codon 201 of G,a, 5’-GTG ATC AAG 
CAG GCT GAC TAT GTG-3’ and 5’-GGT GAA TGT CAA GAA ACC 
ATG-3’ [299-basepair (bp) fragment]; codon 227 of G,oc, 5’.GTC AAC 
TTC CAG TAA GCC AAC-3’ and 5’-CTG GTT GTC CTC CCG GAT 
GAC-3’ (350 bp); codon 179 of Gicu2, 5’CCC CCC ATC CCC AGC 
TAC CT-3’ and 5’-CCG ACC TGT CCA CAT GCT CGC-3’ (168 bp); 
and codon 205 of Gicu2, 5’-GAG AAA TGG GGT AGA AAG CCT-3’ 
and 5’.TCT CAC CAT CTC CTC GTC CTC-3’ (195 bp). Special 
precautions were taken to avoid contamination of the I’CR samples. In 
all PCR experiments, samples containing no DNA were included as 
negative controls. The amplification protocol consisted of denaturation 
at 95 C for 5 min, followed by 30-40 cycles consisting of annealing at 
55 C for 1.5 min, primer extension at 72 C for 1.5 min, and denaturation 
at 94 C for 1 min. All amplified samples were examined by agarose gel 
electrophoresis to confirm successful amplification of each of the regions 
of the Gsa and G,a2 genes. 
Direct sequencing of the PCR product 
In a second, asymmetric PCR, using one of the nested primers in a 
loo-fold excess, single stranded DNA was generated, purified on Ultra- 
pure MC filters (Millipore, Bedford, MA), and lyophilized at room tem- 
perature. Using the dideoxy chain termination method of Sanger et al. 
(1 I), the PCR product was sequenced (T7-DNA polymerase, Sequenase 
2.0, U.S. Biochemical Corp., Cleveland, OH) with [a-35S]deoxy-ATP and 
run on a 6% denaturing polyacrylamide gel. Autoradiography was 
performed with Kodak XAR 2 films (Eastman Kodak, Rochester, NY). 
Results 
In all but two cases, DNA fragments surrounding codons 
201 and 227 of G,LY and codons 179 and 205 of Gia2 were 
successfully amplified by PCR and showed the predicted 
size on agarose gel electrophoresis. In two 31- and 32-yr-old 
paraffin-embedded tumor specimens, the 299- and 350-bp 
long fragments surrounding codons 201 and 227 could not 
be amplified, probably due to DNA degradation, whereas 
the shorter fragments surrounding codons 179 (168 bp) and 
205 (195 bp) could be efficiently amplified in these cases. 
Direct sequencing of the PCR product from normal leu- 
kocyte DNA revealed the wild-type sequence for the ampli- 
fied regions. All adrenal adenomas, all adrenocortical carci- 
nomas, and the two adrenocortical tumor cell lines showed 
only the wild-type sequence at codons 201 and 227 of G,a 
and codons 179 and 205 of Gia2 (Table 2 and Fig. 1). In 
addition, no mutations were found at other codons of G,a 
and G,o12 in these amplifications. 
Discussion 
Constitutively activating mutations in G-proteins were 
found in several endocrine neoplasms. Adenylcyclase activity 
was extremely elevated under basal conditions in these tu- 
mors (12). Clinically, the GH-secreting adenomas were 
smaller in diameter, less responsive to GH-releasing-hor- 
mone, and more sensitive to somatostatin- and dopamine- 
induced GH inhibition than adenomas with no mutated G, 
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9 F 65 4x5x3 Adrenal adenoma Cushing's syndrome Frozen tissue 
10 F 41 3 em diam. Adrenal adenoma Conn's syndrome Frozen tissue 
11 F 49 3 cm diam. Adrenal adenoma Cushing's syndrome Frozen tissue 
12 F 50 1 cm diam. Adrenal adenoma Conn's syndrome Frozen tissue 
13 F 39 4x4x3 Adrenal adenoma Cushing's syndrome Frozen tissue 
14 F 51 1.5 em diam. Adrenal adenoma Conn's syndrome Paraffin 
1."i F 39 2x2x1 Adrenal adenoma Conn's syndrome Paraffin 
16 F 48 3x3x2 Adrenal adenoma Conn's syndrome Paraffin 
17 F 30 4x2x2 Adrenal adenoma Conn's syndrome Paraffin 
18 F 48 1 X 3 Adrenal adenoma Conn's syndrome Paraffin 
Adr. eane., Adrenoeortical carcinoma; met., metastsis; diam., diameter; MEN I, multiple endoerine neoplasia type 1. 
celliine maintained in HITES (containing hydrocortisone, insulin, eth-
anolamine and selenite) medium with 2% fetal bovine, was kindly 
provided by Dr. E. Gazdar (7). 
DNA preparation 
DNA was iso la ted from paraffin-embedded specimens (8), leukocytes, 
or frozen tumor seetions obtained at surgery (9), as previously described. 
Tissue sampies were derived from a central portion of the tumor to 
minimize the possibility of contamination with normal tissue. Repre-
sentative seetions of the tumor material were examined by light micros-
eopy and shown to eonsist of more than 90% tumor cells. For paraffin-
embedded specimens, 10-ILm sections were carefully cut and placed in 
sterile Eppendorf tubes using new gloves, forceps, and a cleaned micro-
tome blade for every tumor block. 
Polymerase chain reaction (PCR) amplification of genomic 
DNA 
PCR was used to amplify DNA fragments surrounding codons 201 
and 227 of Gsa and codons 179 and 205 of G,a2, respectively (10). One 
and 10 IlL DNA preparation from paraffin-embedded tissues or 1 ILg 
DNA from frozen bssue or leukocytic DNA were amplified in a 100-ILL 
PCR mixture containing deoxynucleotide triphosphates (200 Ilmol/L 
each), up- and down-stream oligonucleotide primers (0.3 Ilmol/L each), 
0.01 % gelatin, 50 mmol/L KCI, 10 mmol/L Tris-HCI (pH 8.3),1.5 mmol/ 
L MgCIz, and 2.5 U Taq polymerase (perkin-Elmer Cetus, Norwalk, CT). 
The following primers were used: codon 201 of G,a, 5' -GTG ATC AAG 
CAG GCT GAC TAT GTG-3' and 5' -GGT GAA TGT CAA GAA C 
ATG-3' [299-basepair (bp) fragment]; codon 227 of Gsa, 5' -GTC AAC 
TTC CAG TAA GCC AAC-3' and 5'-CTG GTT GTC CTC CCG GAT 
GAC-3' (350 bp); codon 179 of G;a2, 5'-CCC CCC ATC CCC AGC 
TAC CT-3' and 5'-CCG ACC TGT CCA CAT GCT CGC-3' (168 bp); 
and codon 205 of G;a2, 5'-GAG AAA TGG GGT AGA AAG CCT-3' 
and 5'-TCT CAC CAT CTC CTC GTC CTC-3' (195 bp). Special 
precautions were taken to avoid contaminati n of the PCR sampies. In 
all PCR experiments, sampies containing no DNA were included as 
negative controls. The amplification protocol con isted  de turation 
at 95 C for 5 min, followed by 30-40 cycles consisting of a ne li g at 
55 C for 1.5 mi , primer extension at 72 C for 1.5 in, and den turation 
at 94 C for 1 min. All amplifi d sam pies were examined by agarose gel 
electrophoresis to confirm successful amplification of each of the regions 
of the G,a and Gia2 genes. 
Direct sequencing of the PCR product 
In a second, asymmetrie PCR, using one of the nested primers in a 
100-fold excess, single stranded DNA was generated, purified on Ultra-
pure MC filters (Millipore, Bedford, MA), and lyophilized at room tem-
perature. Using the dideoxy chain termination method of Sanger et al. 
(11), the PCR product was sequenced (T7-DNA polymerase, Sequenase 
2.0, U.S. Biochemical Corp., Cleveland, OH) with [a-35S]deoxy-ATP and 
run on a 6% denaturing polyacrylamide gel. Autoradiography was 
performed with Kodak XAR 2 films (Eastman Kodak, Roehester, NY). 
Results 
In all but two cases, DNA fragments surrounding codons 
201 and 227 of Gsa and codons 179 and 205 of Gja2 were 
successfully amplified by PCR and showed the predicted 
size on agarose gel electrophoresis. In two 31- and 32-yr-old 
paraffin-embedded tumor specimens, the 299- and 350-bp 
long fragments surrounding co dons 201 and 227 could not 
be amplified, probably due to DNA degradation, whereas 
the shorter fragments surrounding codons 179 (168 bp) and 
205 (195 bp) could be efficiently amplified in these cases. 
Direct sequencing of the PCR product from normal leu-
kocyte DNA revealed the wild-type sequence for the ampli-
fied regions. All adrenal adenomas, all adrenocortical carci-
nomas, and the two adrenocortical tumor cell lines showed 
only the wild-type sequence at codons 201 and 227 of Gsa 
and codons 179 and 205 of Ga2 (Table 2 and Fig. 1). In 
addition, no mutations were found at other co dons of Gsa 
and G ja2 in these amplifications. 
Discussion 
Constitutively activating mutations in G-proteins were 
found in several endocrine neoplasms. Adenylcyclase activity 
was extremely elevated under basal conditions in these tu-
mors (12). Clinically, the GH-secreting adenomas were 
smaller in diameter, less responsive to GH-releasing-hor-
mone, and more sensitive to somatostatin- and dopamine-
induced GH inhibition than adenomas with no mutated Gs 
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TABLE 2. Prevalence of oncogenic point mutations in the a-chain 
of G, and GtP in adrenocortical tumors: comparison with the results of 
Lyons et al. (5) 
G.a codon 
n ZOl/codon 
Gicu2 codon 179fcodon 
221(%) 205 (%) 
Adrenal carcinomas 
Reincke et al. 7 0 0 0 
Lyons et al. 6 0 16.6 0 
Adrenocortical tumor cell lines 
Reincke et al. 2 0 0 0 
Adrenal adenomas 
Reincke et al. 11 0 0 0 
Lyons et al. 5 0 40 0 
Gab Codon 179 
NORMAL 
~\LYMPHOCYTES CARCINOMA 1x1 
GATC GATC 
Gaiz Codon 205 
C 
Arg 206 G 11 G 
FIG. 1. Sequencing analysis of the amplified genomic fragments of 
Gia2 surrounding codons 179 and 205 showing only the wild-type 
sequence in normal lymphocytic DNA (left) and DNA from an adre- 
nocortical carcinoma (right). Top, Codon 179; bottom, codon 205. 
(12-14). Somatic mutations in G,cu were also found in benign 
and malignant thyroid neoplasms. Lyons et al. (5) reported a 
low incidence of Gsp mutations in thyroid neoplasms (1 of 
25 cases), whereas Suarez et al. (6) found constitutively 
activating mutations of G,a in 10% of thyroid tumors. Gor- 
etzki et al. (15) reported Gsp mutations in all 25 multinodular 
goiters studied from an iodine-deficient area, but in none of 
3 thyroid adenomas. The Gsp mutations were multifocally 
distributed throughout the tissue. These researchers, there- 
fore, concluded that the Gsp oncogene constituted one of the 
genetic bases of this disease. Whereas Gsp is important in 
endocrine tumors, it does not play a role in the pathogenesis 
of other neoplasms. No Gsp mutations were found in 218 
nonendocrine tumors studied, including breast, colon, and 
gastric carcinomas (5). 
Somatic mutations in a different G-protein, G,cu2, corre- 
sponding to codons 201 and 227 of Gs~, were identified by 
Lyons et al. (5) in 3 of 11 (27%) adrenocortical neoplasms 
using PCR and oligonucleotide-specific hybridization. Al- 
though the functional significance of these putative onco- 
genie mutations Gip 2 was not proven, several indirect lines 
of evidence suggested, promotion of cell proliferation by 
constitutively activated Gia2. However, using PCR and direct 
sequencing, we were unable to confirm the results of Lyons 
et al. None of 7 adrenal carcinomas and 11 adenomas showed 
mutations at codons 179 and 205 of Gia2. In addition, 
although oncogenic mutations are generally more frequent 
in human tumor cell lines than in tumor tissue, the 2 currently 
available human adrenocortical tumor cell lines had wild- 
type sequences at codons 179 and 205 of Gia2. The differ- 
ences between our results and the data of Lyons et al. cannot 
be explained by the different methodologies used in these 
studies. Direct sequencing of PCR-amplified DNA fragments 
is equally sensitive in detecting point mutations in the tumor 
genome compared to allele-specific oligonucleotide hybridi- 
zation, which was used by Lyons et al. More likely, our data 
suggest that the putative oncogene Gip 2 does not play a 
major role in the tumorigenesis of human adrenocortical 
neoplasias. 
Several recent publications suggested that oncogenes other 
than Gip 2 are involved in adrenocortical tumor formation. 
Yano ef al. (16) consistently showed loss of constitutional 
heterozygosity for alleles at chromosomes llq, 13q, and 17p 
in adrenocortical carcinomas, but not in adrenal adenomas 
or hyperplastic adrenal lesions. Chromosome llq seems to 
be important in adrenal tumorigenesis. 1 lq13 is the locus of 
the multiple endocrine neoplasia-1 tumor suppressor gene 
(17), and adrenal tumor formation is part of this entity. 
However, the deletion of the chromosomal region llq13 
present in parathyroid and pancreatic tumors (17) is not 
always present in adrenal tumors of these patients (18). The 
Wiedemann-Beckwith syndrome, which is associated with 
allelic loss of 1 lq15, is characterized by early development 
of Wilm’s tumors and adrenocortical carcinomas (19). Chro- 
mosome 13 is the locus of the retinoblastoma gene (20); 
however, no studies have been reported elucidating the 
pathophysiological significance of retinoblastoma gene mu- 
tations in adrenal neoplasms. The short arm of chromosome 
17 contains the p53 gene, which is most frequently known 
to be mutated in human cancer (21). A germ-line mutation 
in the p53 gene is associated with the Li-Fraumeni syndrome 
in cancer-prone families (22) whose members may develop 
adrenocortical carcinoma (23). In summary, these data to- 
gether with our results show that molecular mechanisms 
different from the previously suggested oncogenes Gsp and 
Gip 2 are involved in the tumorigenesis of adrenocortical 
neoplasms. 
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